share_log

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga ·  Nov 6 11:34

Gainers

  • Sonnet BioTherapeutics (NASDAQ:SONN) stock moved upwards by 77.9% to $7.49 during Wednesday's regular session. The company's market cap stands at $38.9 million.
  • Cytek Biosciences (NASDAQ:CTKB) shares moved upwards by 29.22% to $7.03. The company's market cap stands at $924.4 million. As per the press release, Q3 earnings came out yesterday.
  • Treace Medical Concepts (NASDAQ:TMCI) stock increased by 23.78% to $7.13. The market value of their outstanding shares is at $443.4 million. As per the press release, Q3 earnings came out yesterday.
  • RAPT Therapeutics (NASDAQ:RAPT) shares moved upwards by 21.63% to $2.98. The company's market cap stands at $104.0 million.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock moved upwards by 21.26% to $0.34. The market value of their outstanding shares is at $10.5 million.
  • OptimizeRx (NASDAQ:OPRX) stock increased by 16.24% to $5.94. The company's market cap stands at $108.8 million.

Losers

  • Tango Therapeutics (NASDAQ:TNGX) stock declined by 39.6% to $3.13 during Wednesday's regular session. The company's market cap stands at $335.3 million. As per the press release, Q3 earnings came out today.
  • PACS Group (NYSE:PACS) shares decreased by 39.39% to $17.91. The market value of their outstanding shares is at $2.7 billion.
  • Bluejay Diagnostics (NASDAQ:BJDX) stock declined by 31.98% to $0.09. The market value of their outstanding shares is at $1.5 million.
  • ZyVersa Therapeutics (NASDAQ:ZVSA) shares declined by 31.5% to $1.74. The market value of their outstanding shares is at $1.8 million.
  • Exact Sciences (NASDAQ:EXAS) stock decreased by 27.36% to $51.95. The company's market cap stands at $9.5 billion. The company's, Q3 earnings came out yesterday.
  • Lantheus Holdings (NASDAQ:LNTH) stock decreased by 22.71% to $88.86. The market value of their outstanding shares is at $6.1 billion. As per the news, the Q3 earnings report came out today.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment